Seront, E., Schmitz, S., Papier, M., van Maanen, A., Henry, S., Lonchay, C., . . . Machiels, J. (2019). Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Seront, Emmanuel, Sandra Schmitz, Matthias Papier, Aline van Maanen, Stéphanie Henry, Christophe Lonchay, Sylvie Rottey, Gabrielle van Caloen, 与 Jean-Pascal Machiels. Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic P16-Negative Squamous Cell Carcinoma of the Head and Neck. Frontiers Media S.A, 2019.
Cita MLA (8a ed.)Seront, Emmanuel, et al. Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic P16-Negative Squamous Cell Carcinoma of the Head and Neck. Frontiers Media S.A, 2019.